Article info

Download PDFPDF

Original research
Median time to pain improvement and the impact of baseline pain severity on pain response in patients with psoriatic arthritis treated with tofacitinib

Authors

  1. Correspondence to Dr Kurt de Vlam; kurtdevlam{at}telenet.be
View Full Text

Citation

de Vlam K, Ogdie A, Bushmakin AG, et al
Median time to pain improvement and the impact of baseline pain severity on pain response in patients with psoriatic arthritis treated with tofacitinib

Publication history

  • Received February 1, 2021
  • Accepted May 22, 2021
  • First published July 5, 2021.
Online issue publication 
January 11, 2024
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.